BRPI0412451A - agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável - Google Patents

agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável

Info

Publication number
BRPI0412451A
BRPI0412451A BRPI0412451-0A BRPI0412451A BRPI0412451A BR PI0412451 A BRPI0412451 A BR PI0412451A BR PI0412451 A BRPI0412451 A BR PI0412451A BR PI0412451 A BRPI0412451 A BR PI0412451A
Authority
BR
Brazil
Prior art keywords
treatment
prophylaxis
agonists
irritable bowel
bowel syndrome
Prior art date
Application number
BRPI0412451-0A
Other languages
English (en)
Inventor
Wolfgang Stohle
Rudolf Gottschlich
Juergen Harting
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BRPI0412451A publication Critical patent/BRPI0412451A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"AGONISTAS CAPA EM PARTICULAR PARA O TRATAMENTO E/OU A PROFILAXIA DA SìNDROME DO INTESTINO IRRITáVEL". A presente invenção refere-se a composto da fórmula (I), onde A, R¬ 1¬, R¬ 2¬, R¬ 3¬, X, Y, m e n têm os significados indicados, são adequados para o tratamento da síndrome do intestino Irritável.
BRPI0412451-0A 2003-07-11 2004-06-18 agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável BRPI0412451A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10331723A DE10331723A1 (de) 2003-07-11 2003-07-11 Kappa-Agonisten
PCT/EP2004/006630 WO2005007626A1 (de) 2003-07-11 2004-06-18 Kappa-agonisten insbesondere zur behandlung und/ oder prophylaxe des irritable bowel syndroms

Publications (1)

Publication Number Publication Date
BRPI0412451A true BRPI0412451A (pt) 2006-09-19

Family

ID=34071646

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412451-0A BRPI0412451A (pt) 2003-07-11 2004-06-18 agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável

Country Status (14)

Country Link
US (1) US20060178426A1 (pt)
EP (1) EP1644327A1 (pt)
JP (1) JP2007506677A (pt)
KR (1) KR20060030895A (pt)
CN (1) CN1819994A (pt)
AR (1) AR046153A1 (pt)
AU (1) AU2004256892A1 (pt)
BR (1) BRPI0412451A (pt)
CA (1) CA2531817A1 (pt)
DE (1) DE10331723A1 (pt)
MX (1) MXPA06000366A (pt)
RU (1) RU2006104024A (pt)
WO (1) WO2005007626A1 (pt)
ZA (1) ZA200601228B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
CA2745694C (en) 2008-12-03 2018-03-27 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
EP3013812B1 (en) 2013-06-28 2019-10-16 Nektar Therapeutics Kappa opioid agonists and uses thereof
WO2015042071A1 (en) * 2013-09-19 2015-03-26 Allergan, Inc. Diphenyl urea derivatives as formyl peptide receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US6303611B1 (en) * 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
WO1998049141A1 (en) * 1997-04-30 1998-11-05 Warner-Lambert Company Kappa opioid agonists
DE19849650A1 (de) * 1998-10-29 2000-05-04 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung des Irritable Bowel Syndroms (IBS)

Also Published As

Publication number Publication date
ZA200601228B (en) 2007-05-30
CN1819994A (zh) 2006-08-16
CA2531817A1 (en) 2005-01-27
AR046153A1 (es) 2005-11-30
MXPA06000366A (es) 2006-03-28
KR20060030895A (ko) 2006-04-11
US20060178426A1 (en) 2006-08-10
AU2004256892A1 (en) 2005-01-27
EP1644327A1 (de) 2006-04-12
RU2006104024A (ru) 2006-07-27
JP2007506677A (ja) 2007-03-22
DE10331723A1 (de) 2005-06-16
WO2005007626A1 (de) 2005-01-27

Similar Documents

Publication Publication Date Title
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
ATE484508T1 (de) Furylverbindungen
BRPI0412451A (pt) agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
BRPI0410630A (pt) antagonista de nk1
DE60333746D1 (de) Thienylverbindungen
ATE553077T1 (de) Peptidaseinhibitoren
BR0308081A (pt) Inibidores de histona desacetilase
BRPI0507236A (pt) método para o tratamento ou profilaxia de uma condição, e, composto
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
BRPI0514841A (pt) inibidores de piridila da sinalização de hedgehog, processo de preparação dos mesmos e composição compreendendo os referidos inibidores
BR0014470A (pt) Inibidores de fab i
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
CY1112947T1 (el) Παραγωγα πυρρολης καταλληλα για την θεραπεια πολλαπλασιαστικων ασθενειων
BRPI0409164A (pt) pirazóis substituìdos
EA200601279A1 (ru) Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина
BR0206501A (pt) Inibidores de cruzipaìna e outras cisteìna proteases
NO20054340L (no) Nye sammenkoplede heterocykler og deres anvendelse
BRPI0416156A (pt) uso de tienopirimidinas
ATE554774T1 (de) 2-methylen-19-nor-(20s-24epi)-1alpha,25- dihydrovitamin-d2
BRPI0512784A (pt) tetrahidroquinolinas
BRPI0412862A (pt) derivados da nicotinamida úteis como inibidores de pde4
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]